Skip to main content

Table 1 Laboratory data

From: Ventricular fibrillation immediately after the treatment of Graves’ disease coexisting with atypical angina and long QT syndrome: a case report

 

Normal range

Adimission

Complete Blood Count

 White blood cell count (/µl)

2,700–8,800

6,500

 Red blood cell count (/µl)

3.7–5.4 × 106

4.76 × 106

 Platelet count (/µl)

140.0–340.0 × 103

328 × 103

 Hemoglobin (g/dl)

11.0–17.0

11.9

 Hematocrit (%)

34.0–49.0

41

Biochemistry

 Aspartate aminotransferase (IU/l)

8–38

23

 Alanine aminotransferase (IU/l)

4–44

42

 Lactate dehydrogenase (IU/l)

106–211

149

 Creatine kinase (IU/l)

56–244

180

 CK-MB (IU/l)

 < 25

16

 Sodium (mEq/l)

138–148

140

 Potassium (mEq/l)

3.6–5.2

4.6

 Chlorine (mEq/l)

98–108

101

 Magnesia (mg/dl)

1.8–2.7

1.8

 Calcium (mg/dl)

8.5–10.2

9.2

 Blood urea nitrogen (mg/dl)

8.0–22.6

18.6

 Creatinine (mg/dl)

0.4–0.8

0.69

 Brain natriuretic peptide (pg/ml)

 < 18.4

93.2

 D-Dimer (µg/l)

 < 0.80

0.98

 Troponin T (ng/ml)

 < 0.1

0.203

 Thyroid-stimulating hormone (µlU/ml)

0.5–5.00

 < 0.01

 Free triiodothyronine (pg/ml)

2.3–4.3

 > 32.5

 Free thyroxine (ng/dl)

0.9–1.7

 > 7.77

 Thyroid stimulating hormone receptor antibody (IU/l)

 < 2.0

3.6

 Thyroid-stimulating antibody (%)

 < 120

122